Extracellular vesicle-derived dna vs. Cfdna as a biomarker for the detection of colon cancer

Kavita Thakur, Manu Smriti Singh, Sara Feldstein-Davydova, Victoria Hannes, Dov Hershkovitz, Shlomo Tsuriel*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Liquid biopsy has emerged as a promising non-invasive way to diagnose tumor and monitor its progression. Different types of liquid biopsies have different advantages and limitations. In the present research, we compared the use of two types of liquid biopsy, extracellular vesicle-derived DNA (EV-DNA) and cell-free DNA (cfDNA) for identifying tumor mutations in patients with colon carcinoma. Method: DNA was extracted from the tumor tissue of 33 patients diagnosed with colon carcinoma. Targeted NGS panel, based on the hotspots panel, was used to identify tumor mutations. Pre-surgery serum and plasma were taken from the patients in which mutation was found in the tumor tissue. Extracellular vesicles were isolated from the serum followed by the extraction of EV-DNA. CfDNA was extracted from the plasma. The mutations found in the tumor were used to detect the circulating tumor DNA using ultra-deep sequencing. We compared the sensitivity of mutation detection and allele frequency obtained in EV-DNA and cfDNA. Results: The sensitivity of mutation detection in EV-DNA and cfDNA was 61.90% and 66.67%, respectively. We obtained almost identical sensitivity of mutation detection in EV-DNA and cfDNA in each of the four stages of colon carcinoma. The total DNA concentration and number mutant copies were higher in cfDNA vs. EV-DNA (p value = 0.002 and 0.003, respectively). Conclusion: Both cfDNA and EV-DNA can serve as tumor biomarkers. The use of EV-DNA did not lead to improved sensitivity or better detection of tumor DNA in the circulation.

Original languageEnglish
Article number1171
Issue number8
StatePublished - Aug 2021


  • CfDNA
  • Colon cancer
  • CtDNA
  • EV-DNA
  • Liquid biopsy


Dive into the research topics of 'Extracellular vesicle-derived dna vs. Cfdna as a biomarker for the detection of colon cancer'. Together they form a unique fingerprint.

Cite this